JUPW JUPITER WELLNESS INC

Safety Shot to Develop Detox Product for Alcohol Poising, Plans to File IND with U.S. FDA

Safety Shot to Develop Detox Product for Alcohol Poising, Plans to File IND with U.S. FDA

  • Concentrated form of Safety Shot may be effective as a rapid treatment for alcohol poising which causes 2,200 deaths each year from an estimated 20,000 cases annually in the U.S.
  • Acute alcohol consumption leads to 52 million hospital emergency department visits annually

JUPITER, FL, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced it intends to develop its Safety Shot functional beverage platform in a unique concentrated form to treat alcohol poisoning in hospital and emergency settings. The Safety Shot beverage, set to launch Q4 2023, is the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity.

The Safety Shot platform works through four different Mechanisms of Action including improving central nervous system (CNS) activity, cognition, and motor cortex function. It is designed to rapidly break down blood alcohol levels and prevent residual alcohol in the body from being absorbed through the gut by creating a protective shield around the gut wall.

Over people in the U.S. were admitted to hospital emergency departments due to acute alcohol consumption in 2020. There are an estimated cases of alcohol poisoning each year in the U.S. from alcohol poisoning can include choking, asphyxiation, dehydration, seizures, hypothermia, cardiac arrest, brain damage, and death. According to the U.S. Centers for Disease Control, people die of alcohol poisoning each year in the U.S., or about 6 people each day.

Through its Jupiter Wellness business segment which develops over-the-counter and prescription-grade health and wellness products, Safety Shot has a well-established clinical development infrastructure and expertise.

“We believe a concentrated form of Safety Shot could offer an easy-to-administer, immediately supportive aid or treatment for acute alcohol consumption to help prevent alcohol poisoning and related deaths. With 52 million people rushed to the ER each year due to acute alcohol consumption, we believe that prescription-grade Safety Shot could be used in a variety of settings including ambulances, hospitals, clinics, and entertainment venue-based medical emergency centers,” stated Dr. Glynn Wilson, Safety Shot’s Chief Scientific Officer. “We anticipate filing an investigational new drug (IND) application with the U.S. Food and Drugs Administration (FDA) for this alcohol poisoning related indication.”

About Safety Shot

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. The Company plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for Email Alerts at and by following Jupiter Wellness on and .

Forward Looking Statements

This communication contains forward-looking statements regarding Jupiter Wellness, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jupiter Wellness’ control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness and, including those described from time to time under the caption “Risk Factors” and elsewhere in Jupiter Wellness’ Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness’ Annual Report on Form 10-K for the year ended December 31, 2023 and future filings and reports by Jupiter Wellness. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

Safety Shot Media Contact:

Phone: 561-244-7100

Email: 

###



EN
18/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on JUPITER WELLNESS INC

 PRESS RELEASE

Bonk, Inc. Reports Q3 Financial Results: Emerges Debt-Free with $9 Mil...

Bonk, Inc. Reports Q3 Financial Results: Emerges Debt-Free with $9 Million in Cash and 1,200% Revenue Growth Strategic Transformation Complete: Company Settles Legacy Obligations, Achieves First-Ever Gross Profit in Beverage Segment, and Accelerates Path to Cash Flow Positivity SCOTTSDALE, AZ, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (Nasdaq: BNKK) today reported financial results for the third quarter ended September 30, 2025, marking the completion of its strategic turnaround from its legacy operations as Jupiter Wellness and Safety Shot. The third quarter represents a definitive ...

 PRESS RELEASE

Bonk, Inc. Announces Strategic Board Refresh to Align with New Corpora...

Bonk, Inc. Announces Strategic Board Refresh to Align with New Corporate Vision New Appointments Establish a Bonk-Aligned Majority on the Board of Directors, Adding Deep Expertise in DeFi, Institutional Finance, and High-Growth Digital Asset Operations SCOTTSDALE, AZ, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (Nasdaq: BNKK) today announced the completion of a strategic refresh of its Board of Directors with the appointment of three new members: Connor Klein, an investment partner at New Form Capital, who joined the Board two weeks prior as disclosed in a Form 8-K filing; Stacey Duffy,...

 PRESS RELEASE

BONK, Inc.(나스닥: BNKK) 경영진: 독립 리서치 보고서 “솔라나 기반 수십억 달러 규모 BONK 암호화폐 생태계에...

BONK, Inc.(나스닥: BNKK) 경영진: 독립 리서치 보고서 “솔라나 기반 수십억 달러 규모 BONK 암호화폐 생태계에 접근할 수 있는 대표적 상장사로 자리매김” 결론 Harbinger 보고서, 향후 수년간 큰 폭의 매출 성장 가능성 독립 추정치 제시 Harbinger Research, 강력한 이중 수익 엔진·디플레이션 자산 전략·나스닥에서의 독보적 기회 강조하며 커버리지 개시 애리조나주 스코츠데일, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (나스닥: BNKK, 이하 “회사”)는 솔라나 (Solana) 블록체인 기반 암호화폐 토큰인 BONK의 트레저리를 보유하며, 수익 창출형 제품을 구축하는 커뮤니티 역량 강화에 주력하고 있는 기업이다. 회사는 최근 전략적 전환 이후 독자적인 시장 지위와 높은 성장 잠재력을 분석한 Harbinger Research의 주식 리서치 커버리지 개시를 발표했다. 이 리포트는 나스닥 상장사 중 솔라나 블록체인의 잠재적으로 급성장하는 수십억 달러 규모 BONK 생태계에 대해 규제 환경에서 투자할 수 있는 “최고의 공개 시장 진입 수단” ("premier public-marke...

 PRESS RELEASE

Pengurusan BONK, Inc. (Nasdaq:BNKK) Menyatakan Laporan Penyelidikan Be...

Pengurusan BONK, Inc. (Nasdaq:BNKK) Menyatakan Laporan Penyelidikan Bebas Menunjukkan BONK Berada Pada Kedudukan Strategik Untuk Menjadi Entiti Awam Premier Bagi Ekosistem Kripto BONK Bernilai Berbilion Dolar Melalui Blockchain Solana Laporan Harbinger Menggariskan Anggaran Bebas Firma Tersebut Terhadap Pertumbuhan Hasil Yang Ketara Dalam Beberapa Tahun Akan Datang Harbinger Research Memulakan Liputan, Menyerlahkan Keupayaan Enjin Hasil Berganda Yang Kukuh, Strategi Aset Deflasi Serta Peluang Pelaburan Unik di Nasdaq SCOTTSDALE, Arizona, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (Nas...

 PRESS RELEASE

Administração da BONK, Inc. (Nasdaq: BNKK) Declara que Relatório de Pe...

Administração da BONK, Inc. (Nasdaq: BNKK) Declara que Relatório de Pesquisa Independente Concluiu que a Empresa Está Posicionada a Ser Principal Veículo Público do Ecossistema Cripto de Muitos Bilhões de Dólares Via Solana Blockchain Relatório da Harbinger apresenta um resumo das estimativas independentes da empresa para um crescimento significativo da receita nos próximos anos Harbinger Research Inicia Cobertura, Destacando Poderoso Mecanismo de Receita Dupla, Estratégia Deflacionária de Ativos e Oportunidade Única na Nasdaq SCOTTSDALE, Arizona, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bonk,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch